InsidersTradesSigma
Track the 리메드 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 리메드 has logged 12 insider filings. Market capitalisation: €83bn. The latest transaction was filed on 4 May 2026 (Other). Among the most active insiders: 이근용. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
리메드 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions for healthcare.